Stay updated with breaking news from Jan Lamers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Gene Therapy Market by Type of Therapy, Type of Gene Delivery Method Used, Type of Vector Used, Target Therapeutic Areas, Route of...
DUBLIN--(BUSINESS WIRE)--The "Gene Therapy Market by Type of Therapy, Type of Gene Delivery Method Used, Type of Vector Used, Target Therapeutic Areas, Route of Administration, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.Ge...
Gene Therapies Market Driven by the potential treat the root cause of diseases, the gene therapies pipeline is growing, and the market anticipated to witness substantial growth Success of approved gene therapies has resulted in a surge in interest of biopharmaceutical developers in this rapidly evolving domain. Presently, the ability of gene therapies to treat diverse disease indications is considered among the most prominent drivers of this market. In addition, promising clinical results of pipeline candidates are anticipated to draw in more investments to support product development initiat...
KWPN Stallion Cachet L to Dutch Junior Micky Schelstraete Tue, 12/22/2020 - 07:57 Dutch junior rider Micky Schelstraete has received the ride on the KWPN licensed stallion Cachet L. Cachet L is a 13-year old Dutch warmblood stallion by Jazz out of Jirondine (by Ferro x Nimmerdor). He is bred by Jan Lamers and was originally named Cironn L. Cachet L was licensed at the 2010 KWPN Stallion Licensing and did the 2010 KWPN Autumn Stallion Performance Testing, scoring 81,5 points. In december 2010 he sold to Grand Prix rider Mirelle Witlox-van Kemenade. Cachet L did very little breeding ...